The Turkish Journal of Pediatrics
| |
|
[Summary]
[PDF]
[Mail to Editor ]
[Back]
|
|
Congenital Pulmonary Fibrosarcoma in a Newborn with Hypoglycemia and Respiratory Distress: Case Report
|
|
Davut Şahin1, Nermin Koç1, Şeref Etker2, Şirin Güven3, Cengiz Canpolat4
|
|
Departments of 1Pathology, and 2Pediatric Surgery, Zeynep–Kamil Gynecology and Pediatrics Training and Research
Hospital, and 3Department of Pediatrics, Umraniye Training and Research Hospital, and 4Department of Pediatric
Oncology, Marmara University Hospital, İstanbul, Turkey
|
| Summary | | Although primary bronchopulmonary fibrosarcoma is a rare tumor, it may
be characterized by the symptoms of acute respiratory distress occurring
during the first moments of life in a newborn. It is one of the leading
congenital malignant neoplasms of the lung, but is considered a borderline
tumor since its biological behavior is much more favorable than that of adult
fibrosarcomas. In the absence of metastases, complete resection is curative.
Histopathological diagnosis is not simple, as the microscopic characteristics may
be confused with benign fibromatosis or malignant mesenchymal neoplasms.
In this case report, we present a case of congenital pulmonary spindle cell
tumor showing the features of fibrosarcoma, and we discuss the differential
diagnosis of spindle cell lesions localized within the thorax. |
|
Keywords:
bronchopulmonary fibrosarcoma, congenital, hypoglycemia, newborn,
respiratory distress.
|
| Introduction | | Primary bronchopulmonary fibrosarcoma
(BPFS) is rarely seen, but is the most common
primary malignant congenital tumor of the
lung[1]. These tumors may lead to serious
respiratory distress, in the forms of status
asthmaticus, respiratory distress syndrome,
and fetal asphyxia[]. The diagnosis of these
tumors may be delayed because of some nonspecific
signs and symptoms such as cough,
fever, hemoptysis, fetal anemia, and relapsing
or non-curable pneumonia[]. BPFSs present
as an endobronchial mass, with some showing
a polypoid form and others being localized
intraparenchymally[6]. These tumors may be
congenital or develop at different ages during
childhood.
Although BPFS can be diagnosed using the
advanced imaging methods, the definitive
diagnosis can only be confirmed via cytological
and histopathological assays. Difficulties may
arise during the histological diagnosis of
BPFSs, since the microscopic appearance is
substantially similar to that of fibromatosis
and malignant spindle-cell mesenchymal
neoplasms[7]. The definitive and differential
diagnosis requires immunohistochemical
investigation. Although BPFSs are malignant,
they show a slow progression and have good
prognosis if treated early. Because of their
favorable prognosis after a total resection
despite the tumors histopathologically showing
cellularity and mitotic activity, they are
considered as borderline tumors with lowgrade
malignancy, and total resection has been
reported to be curative[2]. |
| Case Presentation | | Our case was a newborn that presented
with respiratory distress and cyanosis during
breastfeeding 5 to 6 hours after the delivery,
and was admitted to the intensive care
unit. A direct X-ray revealed an opacity of
5x4x3 cm in the middle part of the right
lung, which was considered as pneumonia,
congenital pulmonary cyst, or bronchogenic
cyst, and subsequently an antibiotic therapy
was initiated (Fig. 1). Since the radiological
findings remained unchanged, a computerized
tomography (CT) was taken, and surgical
treatment of the lesion was recommended, with
the diagnosis of bronchogenic cyst (Fig. 2).
Laboratory findings were as follows: erythrocyte
count 3.23x106/ìL (4.7-6.0), hemoglobin 10
g/dl (14-24), white blood cell count 21.3
x103/ìL (4.3-10.3), hematocrit 33% (42-52),
C-reactive protein (CRP) 11.5 mg/dl (0-5), and
blood glucose 21 mg/dl (normal: 40-60).
 | Fig. 1. A tumor in the middle part of the right
lung on the preoperative direct posteroanterior
X-ray. |
The exploration revealed a mass measuring
5x4x3 cm, involving the upper lobe of the
right lung, having a cystic appearance, and
covering a substantial part of the hemithorax.
The mass was completely resected. There was
no spread to the chest wall or mediastinum.
After detecting the hypoplastic and atelectatic
ventilation of the middle and lower lobes,
the operation was terminated with a closed
underwater drainage via the tube thoracostomy.
The patient was supported through mechanical
ventilation during the post-operative period,
and there was no further problem with
respiratory distress. During the follow-up, it
was observed that the air cyst replacing the
resected mass had completely resolved, and a
limited contraction occurred toward that side in
the mediastinum. (The patient’s treatment was
discussed in the Panel of Pediatric Oncology,
Medical Faculty of İstanbul University and
Medical Faculty of Marmara University, and
was considered adequate and sufficient). During
the first days of the surgery, the glucose
level elevated to 40 mg/dl, and normalized
to the physiologic level together with the
other parameters on the following days.
Macroscopic examination revealed no tumor
within the surgical borders of the resected
tissue. The cross-section showed a solid tumor
 | Fig. 2. Computerized tomography scan of the
mass in the right lung. |
tissue of 6x4x3 cm with a regular margin and
off-white in color. Microscopic examination
revealed a cellular tumor tissue composed of
uniform spindle cells, clustered in long and
intersecting fascicles (herringbone pattern),
and collagen deposits in the extracellular areas
(Fig. 3). The spindle cells had an elongated
or oval nucleus, and marked cytoplasm, and
showed 20 mitoses at the 10 high-power
fields (Fig. 4). There was no pleomorphism,
nuclear hyperchromatism, atypia or necrosis.
Based on these morphological findings, the
tumor was diagnosed as fibrosarcoma, and
an immunohistochemical examination was
performed to verify the diagnosis. A strong
diffuse cytoplasmic staining was observed with
vimentin (Fig. 5). There was no staining with
cytokeratin, myoglobin, S-100, smooth muscle
actin, or desmin. Therefore, the diagnosis
of BPFS was definitive. The patient remains
in complete remission 16 months after the
surgical procedure. |
| Discussion |
 | Fig. 3. Intersecting fascicles of spindle-shaped
tumor cells (hematoxylin & eosin x 200). |
When pulmonary lesions are observed
radiologically in newborns and children, some
age-specific congenital abnormalities, such as
adenomatoid malformations and bronchogenic
cysts as well as pneumonia, should be
considered. Thus, in our case, the opacity in
the upper and middle lobes of the right lung
observed on the direct X-rays were diagnosed
as pneumonia, and an antibiotic treatment
was initiated. A subsequent CT scan verified
the diagnosis of bronchogenic cyst, and led to
the surgical treatment. During the childhood
period, preoperative diagnosis of pulmonary
masses is essential for scheduling a surgical
treatment, as in adults. In the suspicious cases,
an intraoperative pathological examination to
determine whether the lesion is mesenchymalderived
is helpful in deciding whether or not
to perform a lymph node dissection. In our
case, the respective surgeon performed a radical
surgical treatment considering the localization
and structure of the mass. If the mass had been
diagnosed histopathologically as pulmonary
carcinoma (rarely seen in children), then an
additional magnetic resonance (MR) imaging
and another surgical procedure would have
been required for the lymph node dissection.
This case demonstrated that a preoperative
pathological examination and perioperative
frozen-section investigation are required in
order to choose the accurate and proper
surgical method.
 | Fig. 4. Pulmonary alveoli in the left lower side,
and a tumor cell showing a mitotic division next
to the alveoli (hematoxylin & eosin x400). |
A preoperative cytological and perioperative
frozen-section-based diagnosis may not
be easy in BPFSs. During the frozensection
investigation, the pathologist may
experience difficulty in differentiating such
lesions from mesenchymal proliferations and
fusiform-cell sarcomas. A pathologist should
primarily keep in mind the possibility of
fibrosarcoma in newborns and infants. The
microscopic appearance may substantially
mimic fibromatosis and spindle cell malignant
mesenchymal tumors[7]. In such cases, it would
be sufficient to inform the surgeon that the
tumor was mesenchymal-derived, and that a
benign-malignant differentiation could not be
made. The histopathologic differential diagnosis
of fibrosarcomas should include plasma-cell
granuloma, fibromatosis, leiomyosarcoma,
malignant fibrous histiocytoma, malignant
melanoma, Schwannoma, and spindle-cell
carcinomas[]. An immunohistochemical
examination in addition to the morphological
findings may be helpful for the differentiation
from other sarcomas. Infantile fibromatosis,
particularly its cellular variant (aggressive
fibromatosis) is one of the most difficult
lesions to diagnose. The signs of fibrosarcomas
include hypercellularity, whether hypocellular
collagenous structures are minimal or absent,
contact between the nuclei of tumor cells,
overlapping nuclei, hyperchromasia, marked
nucleoli, frequent mitosis, necrosis, and
infiltration into the vessel walls[8]. In order
to differentiate from the other spindle-cell
malignant tumors, the definitive diagnosis may
require immunohistochemical, histochemical
and ultrastructural investigations or molecular
biological diagnostic methods in addition to
the conventional histopathological findings.
Demonstrating the silver-binding nucleolar
organizing region (AgNOR) distribution has
been shown to be useful to differentiate the
low-grade fibrosarcomas from the benign
fibrous proliferations[9]. The molecular analysis
showing the ETV6-NTRK3 gene fusion has
been reported to be the most useful method
 | Fig. 5. Diffuse cytoplasmic staining of the tumor
cells with vimentin (hematoxylin & eosin x 200). |
in differentiating between the two entities[].
Some authors suggested that it would be
possible to decide whether these tumors
are benign or malignant only through a
prognosis follow-up for years, even if the
clinical and pathological findings are available
for diagnosis[7].
Fibrosarcomas in the pediatric period, especially
the retroperitoneal fibrosarcomas, may secrete
insulin and similar substances, leading to
hypoglycemia[12]. Although the insulin levels
were not monitored in our case, hypoglycemia
persisted in spite of the parenteral glucose
administration (8 mg/kg/min). This may
indicate a paraneoplastic syndrome caused
by the bioactive peptides secreted from the
neoplastic cells. Normalization of blood glucose
levels 2-3 days after the resection supports
our suggestion.
Congenital infantile fibrosarcomas should
be considered as borderline tumors. The
prognosis of these tumors is much better
than that of fibrosarcomas in adults and
other spindle-cell sarcomas in childhood[].
It has been reported that congenital tumors
have a better prognosis compared to those
occurring in the pediatric period, while those
showing endobronchial localization have a
better prognosis than those showing pulmonary
parenchymal localization[]. Endobronchial
resection and laser therapy are performed for
the treatment of the tumors not spreading out
of the bronchi (e.g. parenchyma) but causing
airway obstruction, whereas surgical procedures
including pneumonectomy or lobectomy are
preferred for the treatment of intraparenchymal
pulmonary fibrosarcomas[14]. Our case was
congenital, showed intraparenchymal
localization, and involved the upper lobe of
the right lung.
Although surgical resection has been proposed
to be curative for the non-metastatic cases,
relapsing cases after the radical surgery
have also been reported[]. Radiotherapy and
chemotherapy are preferred for the unresectable
cases[2]. A combination of surgery, radiotherapy
and chemotherapy may provide a survival rate
of more than 78%[6]. In our case, a complete
remission was achieved without applying any
chemotherapy or radiotherapy after the surgical
procedure. During the 16-month follow-up
after the resection, the CT and MR imaging
scans revealed no mass in the lungs, thorax,
or other organs.
In conclusion, BPFSs may be congenital, or
develop during the pediatric period, and are
considered as borderline or low-grade sarcomas.
These tumors have similar histopathologic
features with benign proliferative lesions
and spindle-cell sarcomas and carcinomas.
The differential diagnosis of the tumors with
similar morphological features can lead to
histopathological misdiagnosis, and thus may
require immunohistochemical, histochemical
and ultrastructural investigations and molecular
biological diagnostic methods, in addition to
the conventional histopathological findings. In
the newborns with hypoglycemia with a mass in
the lung or other organs, the diagnosis of BPFS
should be considered after some pathologies,
such as maternal diabetes and insulinoma,
are ruled out. |
| Reference | 1. Enid G. Potter’s Pathology of the Fetus Infant and
Child (2nd ed). New York: Mosby-Elsevier; 2007:
1139-1140.
2. Savaş Ç, Çandır Ö, Özgüner F. Acute respiratory distress
due to fibrosarcoma of the carina in a child. Pediatr
Pulmonol 2004; 38: 355-357.
3. Desrousseaux B, Gourdin C, Atat I, et al. Fibrosarcome
pulmonaire neo-natal. Chir Pediatr 1989; 30: 295-
296.
4. Picard E, Udassin R, Ramu N, et al. Pulmonary
fibrosarcoma in childhood: fiber-optic bronchoscopic
diagnosis and review of the literature. Pediatr Pulmonol
1999; 27: 347-350.
5. Scheier M, Ramoni A, Alge A, et al. Congenital
fibrosarcoma as cause for fetal anemia: prenatal
diagnosis and in utero treatment. Fetal Diagn Ther
2008; 24: 434.
6. Pettinato G, Manivel JC, Saldana MJ, Peyser J, Dehner
LP. Primary bronchopulmonary fibrosarcoma of
childhood and adolescence: reassessment of a lowgrade
malignancy. Clinicopathologic study of five cases
and review of the literature. Hum Pathol 1989; 20:
463-471.
7. Corsi A, Boldrini R, Bosman C. Congenital-infantile
fibrosarcoma: study of two cases and review of the
literature. Tumori 1994; 80: 392-400.
8. Weiss WS, Goldbulm JR. Enzinger and Weiss’s Soft
Tissue Tumors (5th ed). Philadephia: Mosby; 2008:
304-308.
9. Egan MJ, Raafat F, Crocker J, Smith K. Nucleolar organiser
regions in fibrous proliferations of childhood and
infantile fibrosarcoma. J Clin Pathol 1988; 41: 31-33.
10. Sheng WQ, Hisaoka M, Okamoto S, et al. Congenitalinfantile
fibrosarcoma. A clinicopathologic study of 10
cases and molecular detection of the ETV6-NTRK3
fusion transcripts using paraffin-embedded tissues.
Am J Clin Pathol 2001; 115: 348-355.
11. Alaggio R, Barisani D, Ninfo V, Rosolen A, Coffin C.
Morphologic overlap between infantile myofibromatosis
and infantile fibrosarcoma: a pitfall in diagnosis. Pediatr
Dev Pathol 2008; 11: 355-362.
12. Kumar V, Abbas AK, Fausto N, Mitchell RN. Robbins
Basic Pathology (8th ed).Philadelphia: Saunders-
Elsevier; 2007: 219.
13. Kuhnen C, Harms D, Niessen KH, Diehm T, Müller KM.
Kongenitales pulmonales fibrosarkom. Differenzial
diagnose infantiler pulmonaler spindelzelliger. Tumoren
Pathologe 2001; 22: 151-156.
14. Shankar S, George PJ, Hetzel MR, Goldstraw P.
Elective resection of tumors of the trachea and main
carina after endoscopic laser therapy. Thorax 1990;
45: 493–495. |
|
[Summary ]
[PDF]
[Mail to Editor ]
[Back]
|
|
|